We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Estimates of the prevalence of self-reported long COVID and associated activity limitation, using UK Coronavirus (COVID-19) Infection Survey data.
Findings from the COVID-19 Respiratory Infection Survey. Includes analysis on symptoms reported and the impact of respiratory infection on absence from work and health service utilisation.
Findings from the COVID-19 Respiratory Infection Survey. Includes analysis on symptoms reported and the impact of respiratory infection on absence from work and health service utilisation. Experimental statistics.
Estimates of the prevalence and duration of long-COVID symptoms, and rates of adverse events for hospitalised COVID-19 patients compared with those for matched control patients.
Guidance for managing healthcare staff with symptoms of a respiratory infection including coronavirus (COVID-19), or a positive test result for COVID-19.
Paper prepared by the Office for National Statistics (ONS).
Estimates of the prevalence of self-reported long COVID and associated activity limitation, using data from the COVID-19 and Respiratory Infection Survey. Experimental Statistics.
The Medicines and Healthcare products Regulatory Agency (MHRA) has today (30 January 2024) approved the medicine momelotinib (Omjjara) to treat the symptoms experienced by adult myelofibrosis patients who have moderate or severe anaemia (a low number of red blood cells...
The symptoms, means of transmission, best means of prevention and treatment of hepatitis E.
There have been very rare reports of posterior reversible encephalopathy syndrome (PRES) and reversible cerebral vasoconstriction syndrome (RCVS) with pseudoephedrine.
Government receiving regular updates on a Boil Water Notice from South West Water.
First published during the 2022 to 2024 Sunak Conservative government
Paper prepared by the Scientific Pandemic Influenza Group on Behaviours (SPI-B).
Safety leaflet on topical corticosteroids and withdrawal reactions to help patients and their carers to use these medicines safely.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab).